Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C

Published:2017-05-25 Issue:8 Volume:37 Page:1122-1127
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Virlogeux Victor¹²^ORCID,Pradat Pierre¹²,Hartig-Lavie Kerstin¹²,Bailly François¹²,Maynard Marianne¹²,Ouziel Guillaume¹²,Poinsot Domitille¹²,Lebossé Fanny¹²,Ecochard Marie¹²,Radenne Sylvie¹²,Benmakhlouf Samir¹²,Koffi Joseph¹²,Lack Philippe¹²,Scholtes Caroline²³,Uhres Anne-Claire⁴,Ducerf Christian²⁵,Mabrut Jean-Yves²⁵,Rode Agnès⁶,Levrero Massimo¹²,Combet Christophe²,Merle Philippe¹²,Zoulim Fabien¹²

Affiliation:

1. Department of Hepatology; Groupement Hospitalier Nord; Hospices Civils de Lyon; Lyon France

2. Centre Léon Bérard; Centre de recherche en cancérologie de Lyon; CNRS 5286; Inserm 1052; Université Claude Bernard Lyon 1; Lyon France

3. Department of Virology; Groupement Hospitalier Nord; Hospices Civils de Lyon; Lyon France

4. Department of Pharmacology; Groupement Hospitalier Nord; Hospices Civils de Lyon; Lyon France

5. Department of General Surgery and Liver Transplantation; Groupement Hospitalier Nord; Hospices Civils de Lyon; Lyon France

6. Department of Radiology; Groupement Hospitalier Nord; Hospices Civils de Lyon; Lyon France

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13456/fullpdf

Reference19 articles.

1. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma;El-Serag;Gastroenterology,2012

2. Hepatitis C virus treatment in the real world: optimising treatment and access to therapies: Table 1;Zoulim;Gut,2015

3. Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general population;Meer;JAMA,2014

4. Clinical outcomes in HCV-infected patients treated with direct acting antiviral - 18-month post-treatment follow-up in the French ANRS CO22 HEPATHER Cohort study - EASL 2016;Carrat;J Hepatol,2016

5. Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy;Reig;J Hepatol,2016

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01

2. Assessing the impact of direct-acting antivirals on hepatitis C complications: a systematic review and meta-analysis;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-09-20

3. Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group;Journal of Viral Hepatitis;2022-05-18

4. Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer;Cancers;2022-05-04

5. Postoperative direct‐acting antiviral treatment after liver resection in patients with hepatitis C virus‐related hepatocellular carcinoma;Hepatology Research;2021-09-21